Drug Channels

OCTOBER 4, 2023

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. However, some companies had net price gains. d/b/a Drug Channels Institute.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

JUNE 13, 2023

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. When rebates and discounts were factored in, brand-name drug prices again declined—or grew slowly—in 2022. However, some companies had net price gains. You can find links to each company’s data below.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

MARCH 15, 2022

I am pleased to announce our new 2022 Economic Report on U.S. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. The 2022 Economic Report on U.S. Click to Enlarge].

Specialty Pharmacies 98

Specialty Pharmacies Drug Pricing Pharmaceutical Manufacturing Documentation 98

Drug Channels

JULY 28, 2022

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. Click here to see the original post from May 2022. Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Drug Channels

MAY 10, 2022

Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. When rebates and discounts were factored in, brand-name drug prices declined—or grew slowly—in 2021. That’s why I refer to them as drug pricing flat earthers (#DPFE). d/b/a Drug Channels Institute.

Drug Pricing 98

Drug Pricing Pharmaceutical Manufacturing 98

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 in 2022 to JPY9.498 trillion ($68.08 One reason at play is the concern that the Japanese pharmaceutical industry has shown about the impact of annual price revisions.

Drug Pricing 69

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 69

FDA Law Blog: Biosimilars

AUGUST 14, 2024

Gaulkin — Enacted in 2022, the Inflation Reduction Act (IRA) amended the Medicare provisions of the Social Security Act to impose several discount requirements on pharmaceutical manufacturers. Kirschenbaum & Michelle L. Butler & Faraz Siddiqui & Sophia R.

Drug Pricing 59

Drug Pricing Pharmaceutical Manufacturing 59